These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 18775919)

  • 1. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.
    Hajer GR; van Haeften TW; Visseren FL
    Eur Heart J; 2008 Dec; 29(24):2959-71. PubMed ID: 18775919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White adipose tissue and cardiovascular disease.
    Matsuzawa Y
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):637-47. PubMed ID: 16311222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue.
    Lafontan M; Girard J
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):317-27. PubMed ID: 18550411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
    Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine and signalling role of adipose tissue: new perspectives on fat.
    Trayhurn P
    Acta Physiol Scand; 2005 Aug; 184(4):285-93. PubMed ID: 16026420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fat mass expansion, fatty acids and adipokines: metabolic markers and risk factors for cardiovascular pathologies].
    Lafontan M
    Ann Pharm Fr; 2013 Jan; 71(1):13-26. PubMed ID: 23348852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
    Goralski KB; Sinal CJ
    Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
    You T; Yang R; Lyles MF; Gong D; Nicklas BJ
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of fat topology in the risk of disease.
    Matsuzawa Y
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S83-92. PubMed ID: 19136997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
    Skurk T; Hauner H
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adipose tissue: a multifunctional organ].
    Bon GB
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):23S-28S. PubMed ID: 18773748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral obesity and the heart.
    Mathieu P; Pibarot P; Larose E; Poirier P; Marette A; Després JP
    Int J Biochem Cell Biol; 2008; 40(5):821-36. PubMed ID: 18201922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
    Martínez-Clemente M; Clària J; Titos E
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.
    Wajchenberg BL; Giannella-Neto D; da Silva ME; Santos RF
    Horm Metab Res; 2002; 34(11-12):616-21. PubMed ID: 12660870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease.
    Matsuzawa Y
    Nat Clin Pract Cardiovasc Med; 2006 Jan; 3(1):35-42. PubMed ID: 16391616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.